Progression of retinopathy in insulin-treated type 2 diabetic patients

Diabetes Care

Volumn 25, Issue 2, 2002, Pages 381-385

  Henricsson, Marianne ^a,b   Berntorp, Kerstin ^a   Fernlund, Per ^a   Sundkvist, Göran ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Department of Ophthalmology ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; SOMATOMEDIN C; ANTIDIABETIC AGENT;

ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; AGED; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; STATISTICAL MODEL; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036479861     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.2.381     Document Type: Article

References (28)

1. Kohner EM: Diabetic retinopathy. BMJ 307:1195-1993, 1993
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Reichard P, Nilsson B-Y, Rosenqvist U: The effect of long term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
4. U.K. Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
5. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O, Aker Diabetes Group: Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus: the Oslo study. BMJ 290:811-815, 1985
6. Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T: The Steno Study Group: two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 34 (Suppl. 3):74-79, 1985
7. Kroc Collaborative Study Group: Diabetic retinopathy after two years of intensified insulin treatment. JAMA 260:37-41, 1988
8. The Diabetes Control and Complications Trial Research Group: Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 116:874-886, 1998
9. Henricsson M, Berntorp K, Berntorp E, Fernlund P, Sundkvist G: Progression of retinopathy after improved metabolic control in type II diabetic patients: relation to IGF-1 and hemostatic variables. Diabetes Care 22:1944-1949, 1999
10. Clauson P, Linnarsson R, Gottsāter A, Sundkvist G, Grill V: Relationships between diabetes duration, metabolic control and β-cell function in a representative population of type 2 diabetic patients. Diabet Med 11:794-801, 1994
11. Sundkvist G, Lilja B, Almér LO: Absent elevations in growth hormone, factor VIII related antigen, and plasminogen activator activity during exercise in diabetic patients resistant to retinopathy. Diabetes Res 7:25-30, 1988
12. Poulsen J: The Houssay phenomen in man: recovery from retinopathy in a case of diabetes with Simmond's disease. Diabetes 2:7-12, 1953
13. Lundbaek K: Growth hormone's role in diabetic microangiopathy. Diabetes 25 (Suppl. 2):845-849, 1976
14. LeRoith D: Insulin-like growth factors. N Engl J Med 336:633-640, 1997
15. Merimee TJ, Zapf J, Froesch ER: Insulin-like growth factors: studies in diabetics with and without retinopathy. N Engl J Med 309:527-530, 1983
16. Chantelau E, Seppel T, Althaus C, Schōnau E: Elevation of serum IGF-1 rather than sex steroids precedes proliferative retinopathy in Mauriac's syndrome. Horm Res 48:131-134, 1997
17. Chantelau E: Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy. Br J Ophthalmol 82:725-730, 1998
18. Grant MB, Mames RN, Fitzgerald C, Hazariwala KM, Cooper-DeHoff R, Caballero S, Estes KS: The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy. Diabetes Care 23:504-509, 2000
19. 1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32:1867-1872, 1986
20. Gottsāter A, Landin-Olsson M, Fernlund P, Gullberg B, Lernmark Å, Sundkvist G: Pancreatic beta-cell function evaluated by intravenous glucose and glucagon stimulation: a comparison between insulin and C-peptide to measure insulin secretion. Scand J Clin Lab Invest 52:631-639, 1992
21. Klein R, Klein BEK, Magli YL, Brothers RJ, Meuer SM, Davis MD: An alternative method of grading diabetic retinopathy. Ophthalmology 93:1183-1187, 1986
22. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy IX: four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 107:237-243, 1989
23. Matthews JNS, Altman DG, Campbell MJ, Royston P: Analysis of serial measurements in medical research. BMJ 300:230-235, 1990
24. Clauson PG, Brismar K, Hall K, Linnarsson, Grill V: Insulin-like growth factor-1 and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. Scand J Clin Lab Invest 58:353-360, 1998
25. King GL, Goodman AD, Buzney S, Moses A, Kahn CR: Receptors and growth promoting effects of insulin and IGF-1 on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-1036, 1985
26. Grant MB, Caballero S, Millard WJ: Inhibition of IGF-1 and b-FGF stimulated growth of human retinal endothelial cells by the somastotatin anlaogue, ocreotide: a potential treatment for ocular neovascularization. Regul Pept 48:267-278, 1993
27. Smith LE, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, Foley E, Smith RG, Schaeffer JM: Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276:1076-1709, 1997
28. Smith LEH, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bishoff J, Zhang B, Schaeffer JM, Senger DR: Regulation of vascular endothelial growth factor-dependent retinal neo-vascularization by insulin-like growth factor-1 receptor. Nature Med 5:1390-1395, 1999